Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.
NHS England proposes that patients likely to achieve the greatest clinical benefit from weight loss are prioritised to receive the medication in a variety of new services that will be tested before an ...
Proposals for a phased launch of the obesity injection tirzepatide have been set out, as a consultation begins. NHS England ...
In a phased rollout, the jabs eventually will be offered to those with a BMI of 35 or more and weight-related health problems ...
The longshoreman’s strike shutting down ports along the East and Gulf Coasts may cause a significant shortage of widely used ...
The cost of taking weekly injections of popular anti-obesity medications liraglutide (Saxenda) or semaglutide (Wegovy) exceeds that of metabolic and bariatric surgery in less than a year, according to ...